市場調査レポート
商品コード
1416293
感染症診断市場レポート:2030年までの動向、予測、競合分析Infectious Disease Diagnostics Market Report: Trends, Forecast and Competitive Analysis to 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
感染症診断市場レポート:2030年までの動向、予測、競合分析 |
出版日: 2024年01月29日
発行: Lucintel
ページ情報: 英文 150 - page report
納期: 3営業日
|
世界の感染症診断市場は、2024年から2030年までのCAGRが5.1%で、2030年までに推定499億米ドルに達すると予想されています。この市場の主な促進要因は、感染症の蔓延の増加と病気の早期発見に対する意識の高まりです。世界の感染症診断市場の将来は、免疫診断、NGS、INAAT、PCR市場での機会により有望に見えます。
Lucintelは、試薬、キット、および消耗品が、これらの製品の反復使用により、予測期間を通じて引き続き最大のセグメントになると予測しています。
この市場においては、新型コロナウイルス感染症(COVID-19)検査やPOC感染症検査などにおけるイムノアッセイの使用が増加しているため、免疫診断が引き続き最大のセグメントとなると思われます。
北米は、この地域における高い感染率、確立されたヘルスケアインフラ、ヘルスケア支出の増加により、予測期間を通じて最大の地域であり続けるでしょう。
Q1.市場規模は:
A1.世界の感染症診断市場は、2030年までに推定499億米ドルに達すると予想されています。
Q2.市場の成長予測は:
A2.世界の感染症診断市場は、2024年から2030年にかけて5.1%のCAGRで成長すると予想されています。
Q3.市場の成長に影響を与える主な促進要因は:
A3.この市場の主な促進要因は、感染症の蔓延の増加と、病気の早期発見に対する意識の高まりです。
Q4.市場の主要セグメントは:
A4.感染症診断市場の将来は、免疫診断、NGS、INAAT、およびPCR市場での機会により有望に見えます。
Q5.市場の主要企業は:
A5.主要な感染症診断会社は次のとおりです。
Q6.今後、最大となる市場セグメントは:
A6.Lucintelは、試薬、キット、および消耗品が、これらの製品の繰り返し使用により、予測期間を通じて引き続き最大のセグメントになると予測しています。
Q7.市場において、今後5年間に最大になると予想される地域は:
A7.北米は、この地域における高い感染率、確立されたヘルスケアインフラ、ヘルスケア費の増加により、予測期間を通じて最大の地域であり続けるでしょう。
Q8.レポートのカスタマイズは可能か:
A8.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。
The future of the global infectious disease diagnostics market looks promising with opportunities in the immunodiagnostics, NGS, INAAT, and PCR markets. The global infectious disease diagnostics market is expected to reach an estimated $49.9 billion by 2030 with a CAGR of 5.1% from 2024 to 2030. The major drivers for this market are increasing prevalence of infectious diseases and the rising awareness about early disease detection.
A more than 150-page report is developed to help in your business decisions.
The study includes a forecast for the global infectious disease diagnostics by product, test type, technology, end use, and region.
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies infectious disease diagnostics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the infectious disease diagnostics companies profiled in this report include-
Lucintel forecasts that reagents, kits, and consumables will remain the largest segment over the forecast period due to recurrent usage of these products.
Within this market, immunodiagnostics will remain the largest segment due to increasing usage of immunoassays in COVID-19 testing, POC infectious disease testing, and others.
North America will remain the largest region over the forecast period due to high incidence of infections, established healthcare infrastructure, and rising healthcare expenditure in the region.
Market Size Estimates: Infectious disease diagnostics market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Infectious disease diagnostics market size by various segments, such as by product, test type, technology, end use, and region in terms of value ($B).
Regional Analysis: Infectious disease diagnostics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different products, test types, technologies, end uses, and regions for the infectious disease diagnostics market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the infectious disease diagnostics market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
Q1. What is the infectious disease diagnostics market size?
Answer: The global infectious disease diagnostics market is expected to reach an estimated $49.9 billion by 2030.
Q2. What is the growth forecast for infectious disease diagnostics market?
Answer: The global infectious disease diagnostics market is expected to grow with a CAGR of 5.1% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the infectious disease diagnostics market?
Answer: The major drivers for this market are increasing prevalence of infectious diseases and the rising awareness about early disease detection.
Q4. What are the major segments for infectious disease diagnostics market?
Answer: The future of the infectious disease diagnostics market looks promising with opportunities in the immunodiagnostics, NGS, INAAT, and PCR markets.
Q5. Who are the key infectious disease diagnostics market companies?
Answer: Some of the key infectious disease diagnostics companies are as follows:
Q6. Which infectious disease diagnostics market segment will be the largest in future?
Answer: Lucintel forecasts that reagents, kits, and consumables will remain the largest segment over the forecast period due to recurrent usage of these products.
Q7. In infectious disease diagnostics market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to high incidence of infections, established healthcare infrastructure, and rising healthcare expenditure in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.